Abstract
Metabolic ataxias are rare. They usually start in the childhood and often have autosomal recessive inheritance. They may also present in adulthood. The diagnosis is important since some patients may be successfully managed with diet and treatments.
Keywords: Adult metabolic ataxia, copper storage, energy metabolism defect, peroxisomal, storage disease, vitamin E deficiency.
Current Molecular Medicine
Title:Metabolic Ataxias in Adults
Volume: 14 Issue: 8
Author(s): A. Antenora, A. Filla, F.M. Santorelli, S. Peluso, F. Sacca and G. De Michele
Affiliation:
Keywords: Adult metabolic ataxia, copper storage, energy metabolism defect, peroxisomal, storage disease, vitamin E deficiency.
Abstract: Metabolic ataxias are rare. They usually start in the childhood and often have autosomal recessive inheritance. They may also present in adulthood. The diagnosis is important since some patients may be successfully managed with diet and treatments.
Export Options
About this article
Cite this article as:
Antenora A., Filla A., Santorelli F.M., Peluso S., Sacca F. and Michele De G., Metabolic Ataxias in Adults, Current Molecular Medicine 2014; 14 (8) . https://dx.doi.org/10.2174/1566524014666141010131213
DOI https://dx.doi.org/10.2174/1566524014666141010131213 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Age-Related Sleep Changes and its Implication in Neurodegenerative Diseases
Current Aging Science Hypothyroidism and Endothelial Function: A Marker of Early Atherosclerosis?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Design, Synthesis and Biological Evaluation of 3-(2-(benzo[d]thiazol-2- ylthio)acetamido)benzoic Acid Derivatives as Inhibitors of Protein Tyrosine Phosphatase 1B
Letters in Drug Design & Discovery High Haematocrit Blood Flow and Adsorption of Micro and Nanoparticles on an Atherosclerotic Plaque: An In-silico Study
Current Drug Delivery Molecular and Pathophysiological Mechanisms of Diabetic Retinopathy in Relation to Adhesion Molecules
Current Diabetes Reviews Design and Development of Preservative Free Herbal Dosage Forms
The Natural Products Journal The Platelet ATP and ADP Receptors
Current Pharmaceutical Design Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews Non-Communicable Diseases and Adherence to Mediterranean Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets Cellular Stress and General Pathological Processes
Current Pharmaceutical Design SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System
Infectious Disorders - Drug Targets <i>In Silico</i> Evaluation of Various Signal Peptides to Improve Secretion of Humulin Protein in <i>E. coli</i> Host
Current Proteomics Improvement in Hypertension Management with Pharmacological and Non- Pharmacological Approaches: Current Perspectives
Current Pharmaceutical Design Aspergillus Biotechnology: An Overview on the Production of Hydrolases and Secondary Metabolites
Current Biotechnology Visfatin: Structure, Function and Relation to Diabetes Mellitus and Other Dysfunctions
Current Medicinal Chemistry Is C-Peptide Replacement the Missing Link for Successful Treatment of Neurological Complications in Type 1 Diabetes?
Current Drug Targets Insight into p95HER2 in Breast Cancer: Molecular Mechanisms and Targeted Therapies
Recent Patents on DNA & Gene Sequences Editorial [Hot Topic:Botanical Treatments for Diabetes and Obesity (Guest Editor: Jianping Ye)]
Endocrine, Metabolic & Immune Disorders - Drug Targets Large Granular Lymphocyte (LGL) Leukemia: Pathobiology, Diagnosis and Treatment
Current Cancer Therapy Reviews Covid 19 May Limit the Use of Anti-hyperglycemic Agents. Does it Call for the Development of New Anti-hyperglycemic Agents?
Current Diabetes Reviews